Skip to Content

Nuveen International Eq Idx Advisor TCIHX

Medalist Rating as of | See Nuveen Investment Hub
  • NAV / 1-Day Return 22.89  /  +0.97 %
  • Total Assets 24.3 Bil
  • Adj. Expense Ratio
    0.190%
  • Expense Ratio 0.190%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment
  • Status Open
  • TTM Yield 2.89%
  • Turnover 5%

USD | NAV as of May 03, 2024 | 1-Day Return as of May 03, 2024, 10:21 PM GMT+0

Morningstar’s Analysis TCIHX

Will TCIHX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A sound investment process and strong management team underpin TIAA-CREF International Eq Idx Advisor's Morningstar Medalist Rating of Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings TCIHX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 15.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

2.29 551.8 Mil
Healthcare

ASML Holding NV

2.25 541.9 Mil
Technology

Nestle SA

1.63 392.3 Mil
Consumer Defensive

Toyota Motor Corp

1.50 361.8 Mil
Consumer Cyclical

Lvmh Moet Hennessy Louis Vuitton SE

1.48 357.0 Mil
Consumer Cyclical

Novartis AG Registered Shares

1.22 293.0 Mil
Healthcare

Shell PLC

1.18 284.9 Mil
Energy

SAP SE

1.15 277.2 Mil
Technology

AstraZeneca PLC

1.15 276.8 Mil
Healthcare

Msci Eafe Mar24 Ifus 20240315

1.10 264.7 Mil